Significantly lower relapse rate for TEL/AML1-positive ALL

Leukemia. 1999 Oct;13(10):1633. doi: 10.1038/sj.leu.2401500.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artificial Gene Fusion
  • Burkitt Lymphoma / epidemiology
  • Burkitt Lymphoma / genetics*
  • Czechoslovakia / epidemiology
  • Humans
  • Incidence
  • Neoplasm Proteins / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Recurrence
  • Translocation, Genetic

Substances

  • Neoplasm Proteins